Financial

Fountain Life Appoints Rakesh M. Suri, M.D., D.Phil., as President and Chief Medical Officer

Prominent Cardiac Surgeon and Former Cleveland Clinic Leader to Drive Global Growth of Preventative Health Company  NAPLES, Fla., Oct. 13, 2022 /PRNewswire/ — Fountain Life, a preventative health and longevity company committed to transforming global healthcare from reactive to proactive, today announced the appointment of Rakesh M. Suri, M.D., D.Phil., as the company’s […]

Aziyo Biologics Strengthens Leadership Team and Organizes for Growth in Key Markets

Senior team enhanced to advance Aziyo’s commercial and financial objectives SILVER SPRING, Md., Oct. 11, 2022 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a biological device company with a portfolio of commercial products across four distinct businesses, today announced key promotions and new hires that solidify its position as […]

Ancora Heart Appoints David J. Tucker as Chief Financial Officer

Senior Financial Leader is Company’s Second C-Level Hire in 2022 SANTA CLARA, Calif.–(BUSINESS WIRE)–Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure (HF), today announced that David J. Tucker has joined the company as chief financial officer. He will direct the company’s financial strategies and […]

HeartBeam Names Peter J. Fitzgerald, MD, PhD, as Chief Medical Officer

Renowned Stanford Cardiologist Brings Deep Clinical, Research, and Industry Expertise to Executive Team SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, today announced the appointment of Peter J. Fitzgerald, MD, PhD, […]

iCAD and Solis Mammography Ink Deal to Collaborate on Use of AI to Evaluate Risk of Cardiovascular Disease

Multi-year strategic research and commercial collaboration agreement aims to significantly impact preventative care and underscores Company’s commitment to women’s health NASHUA, N.H., Oct. 11, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced a new development and commercial collaboration […]

Medcura Names New Surgical Scientific Advisory Board

Accomplished surgeons will provide expert guidance on Medcura’s clinical, technical and market development. RIVERDALE, Md., Oct. 11, 2022 /PRNewswire/ — Seven top cardiothoracic, general, trauma, veterinary, and neurosurgeons will lead commercial-stage life science and medical device company Medcura Inc.’s new Surgical Scientific Advisory Board guiding the development and commercialization of its platform of surgical hemostats. […]

AtriCure to Announce Third Quarter 2022 Financial Results

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its third quarter 2022 financial results on Tuesday, November 1, 2022. AtriCure will host an audio webcast at […]

Translumina further strengthens senior leadership to drive next phase of growth

NEW DELHI, Oct. 10, 2022 /PRNewswire/ — Translumina – a global developer and manufacturer of innovative cardiovascular medical devices, implants and access products – appointed Indranil Mukherjee as Group CEO and Armin Kiser as Managing Director and Chief Operating Officer for the company’s Europe operations. Indranil is a veteran in the healthcare industry. In his most recent role […]

scPharmaceuticals Announces $100 Million Debt Financing Agreement with Oaktree

Funds to be used to facilitate U.S. commercial launch of FUROSCIX® BURLINGTON, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, […]

Mana Capital Acquisition Corp. Announces Effectiveness of Registration Statement and October 25, 2022 Special Meeting of Stockholders to Approve Business Combination with Cardio Diagnostics, Inc.

DOVER, Del.–(BUSINESS WIRE)–Mana Capital Acquisition Corp. (“Mana Capital”) (Nasdaq: MAAQU; MAAQ; MAAQW; MAAQR), a publicly traded special purpose acquisition company, today announced that its registration statement on Form S-4, relating to the previously announced business combination between Mana Capital and Cardio Diagnostics, Inc. (“Cardio”), a pioneering precision cardiovascular testing company, […]